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Summary: Purpose: Several experimental models of human
temporal lobe epilepsy have shown that apoptotic death of neu-
rons is an important part of this degenerative disease. However,
the role of apoptotic regulators is not clear during the epilep-
togenesis. Therefore we investigated the expression pattern of
bcl-2 family of genes during the formation of kindling model of
epilepsy in rats.
Methods: We examined the expression pattern of bax, bcl-2,
bcl-xL, mtd, and bcl-w both at messenger RNA (mRNA) and pro-
tein level in the brain tissues during the formation of epilepsy
with kindling model in adult rats, which has been the most ac-
ceptable form of experimental model of human epilepsy. We also
assessed the onset of DNA fragmentation by using the terminal
deoxynucleotidyl transferase–mediated dUTP nick-end labeling
(TUNEL) assay.
Results: Animals have started to have epileptic discharges af-
ter day 10 of kindling model. Recurrent subthreshold electrical
stimuli induced not only epileptic foci but also the expression
of bax, an inducer of apoptosis, in this time period. Conversely,
bcl-xL, which is an inhibitor of apoptosis, had an opposite pat-
tern of expression both at mRNA and protein level during the
formation of epilepsy. We did not observe DNA fragmentation
by TUNEL staining.
Conclusions: Our study shows differential expression of Bax
and Bcl-xL at the CA1 region during the formation of hippocam-
pal kindling model. The absence of DNA fragmentation during
this period suggests that epileptic changes in neurons have the po-
tential to induce DNA fragmentation by altering the expression
levels of Bax and Bcl-xL. Key Words: Apoptosis—Kindling—
Bcl-2 family of genes—Epilepsy—Rat.
Selective neuronal loss in hippocampus is frequently
associated with human temporal lobe epilepsy (1–3).
Exitotoxicity-induced necrosis has long been thought to
be the mechanism of neuronal damage during the induc-
tion of epilepsy (4–7). However, several recent studies also
implied that neurons die via apoptosis after such an injury
(8–12). Apoptotic death of neurons also has been shown
in several experimental models of human temporal lobe
epilepsy including kindling (10,12).
In kindling model of epilepsy, repeated subconvulsive
electrical stimulation eventually results in generalized
seizures (13,14). Postmortem analysis of humans with
chronic idiopathic epilepsy suggests that neuronal dam-
age is cumulative and related to the frequency of seizures
(15). Therefore the kindling model of epilepsy seems to
possess several features that may be related to clinical
problems of epilepsy. By using this experimental model,
it has been shown that administration of protein synthesis
inhibitor, cyclohexamide, prevented the onset of apoptosis
in brain, suggesting that protein synthesis is required in
this process (10).
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Apoptosis has been crucial for normal development
of several systems including nervous system. Extensive
studies performed over the last 10-year period revealed
a large part of the molecular basis of apoptosis made it
clear that the disruption in apoptotic pathways results in
many pathologic conditions. Therefore the molecular reg-
ulators of the apoptosis have a vital importance in living
organisms. Among these, Bcl-2 family of proteins deter-
mines the life or death of a cell by controlling the re-
lease of mitochondrial apoptogenic factors, cytochrome c,
and apoptosis-inducing factors (AIFs), which activate the
downstream executional phases, including the activation
of the caspases (16,17). The bcl-2 family of genes con-
sists of both pro- and antiapoptotic genes, and by forming
dimers, they exert their function. The ratio of death antag-
onists (Bcl-2, Bcl-xL) to agonists (Bax) has been shown
to have a critical role in determining the fate of the cells
(18,19). The Bcl-2 family proteins also are key candi-
dates in contributing to seizure-induced neuronal death
outcome. Alterations within the Bcl-2 family of proteins,
including Bax, Bcl-2, Bcl-XS, Bcl-XL and Bcl-w, have
been shown both in human temporal lobe epilepsy (20–22)
and in different experimental murine models of epilepsy
(12,23–32). Among these, by using the amygdala-
kindled model, Zhang et al. (12) found that the mRNA
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expression of bax but not bcl-2 was increased in rat brains
after kindled seizures (12).
However, to our knowledge, the participation of the bcl-
2 family of genes has not been investigated during the
formation period of the kindled form of epilepsy. In addi-
tion, it is not clear whether this neuronal death is directly
involved in epileptogenesis or occurs secondary to the ef-
fects of the severe and prolonged seizures. To elucidate
the role of bcl-2 family of genes and apoptosis during
epileptogenesis, we investigated the expression pattern of
the different bcl-2 genes both at mRNA and protein level,
by monitoring at different stages of the kindling model
of epilepsy in rats. Our observations provide insight into
the involvement of the Bcl-2 family of proteins during
epileptogenesis.
METHODS
Animals
Male, 9-week-old, 280- to 300-g Sprague–Dawley rats
were used. They were housed under controlled environ-
mental conditions (22◦C) with a 12-h light and 12-h dark
cycle in the animal holding facility of the Department of
Molecular Biology and Genetics at the Bilkent Univer-
sity, Turkey. All the animals received care according to
the criteria outlined in the “Guide for Care and Use of
Laboratory Animals” prepared by the National Academy
of Science, and this study protocol complied with Bilkent
University’s guidelines on humane care and use of lab-
oratory animals. The animals were permitted unlimited
access to food and water at all times. Before used in the
experiments, the rats were allowed to adapt the new con-
ditions for ≥1 week. Animals were randomly divided into
three groups: one group was implanted with electrodes
and received electrical impulses, the other group of an-
imals was implanted with electrodes but did not receive
electrical impulses and served as a sham group, and the
last group of animals was neither implanted with elec-
trodes nor stimulated with electrical impulses, and thus
served as a control group. Animals were killed 1, 3, 7, 10,
and 14 days after the electrical impulse (n = 3 at each
time point) with corresponding sham and control groups
of animals.
Kindling procedure
Rats were anesthetized by using phenobarbital (PB; 50
ml/kg, i.p.) and placed in a stereotaxic frame. A bipolar,
plastic-coated stainless-steel electrode was implanted into
the right ventral hippocampal CA1 region at the following
coordinates: tooth-bar at 0: 4.8 mm caudal to bregma, 5.2
mm lateral to midline, and 6.5 mm ventral to dura (33). A
reference electrode was placed between the skull and left
temporal muscle. Ten days after surgery, we started to give
one kindling stimulation (1-s, 100-Hz biphasic pulses of
1-ms duration, 400 µA peak-to-peak amplitude delivered
by a stimulator) every day for 14 days. Animals were killed
1, 3, 7, 10, and 14 days after the initial stimulus. Behav-
ioral seizures were scored as follows (34): grade 0, normal
behavior, wet-dog shakes, arrest; 1, facial twitches; 2, head
nodding, chewing; 3, forelimb clonus; 4, rearing, falling
on forelimbs; 5, falling on the side or back, hindlimb
clonus. Electroencephalographic activity was monitored
by a Nihon-Kohden 14-channel EEG recorder.
Tissue fixation, synthesis of sense and antisense
mRNAs, and in situ hybridization protocols
Rats were killed and their brains were quickly re-
moved and cryopreserved by putting them into 4% cold
paraformaldeyde for 18 h and then into 30% sucrose
for 24 h. The full-length rat bax, bcl-2, bcl-w, mtd, and
bcl-xL were cloned into pGEM4Z (Promega, Madison,
WI, U.S.A.) and pBluescript II SK+ (Stragene, La Jolla,
CA, U.S.A.) expression vectors. After linearization with
the appropriate restriction enzymes, digoksin-labeled an-
tisense or sense RNAs were synthesized by using the
Dig RNA labeling kit (Roche Diagnostics, Mannheim,
Germany), according to the manufacturer’s protocol. After
ethanol precipitation, the probes were stored at –70◦C until
used. The 15-µm cryosections were placed on the Silane-
treated slides and were hybridized with 10 ng digoksin-
labeled bax, bcl-2, bcl-w, mtd, and bcl-xL probe at 30µl hy-
bridization buffer consisting 40% deionized formamide,
10% dextran sulfate, ×1 Denhardt’s solution (0.002%
Ficoll, 0.02% polyvinylpyrrolidone, 10 mg/ml Rnase-free
bovine serum albumin), ×4 SSC, 10 mM DDT, 1 mg/ml
yeast t-RNA, and 1 mg/ml denatured and sheared salmon
sperm DNA. Sense and antisense probes were placed on
the upper and lower half of every slide, respectively, and
separate coverslips were used for these sections. Slides
were placed horizontally in a sealed, humidified container
and incubated at 42◦C for 16 h; then the coverslips were
removed, and slides were washed with ×2 SSC and ×1
SSC for 15 min each and subjected to 30-min incubation
at 37◦C with NTE buffer (500 mM NaCl, 10 mM Tris,
and 1 mM EDTA, pH 8.0) containing 20 µg/ml Rnase
A to digest any single-stranded RNA probe. To visualize
the bound probes, slides were then incubated with AP-
labeled anti-digoksin antibody at 1:500 dilution at 4◦C for
16 h. Slides were then incubated with NBT/BCIP as sub-
strate with 10 mM levamisole to block endogenous AP
activity. Then the slides were examined by using a Zeiss-
Axioskop microscope at×4,×10, and×40 magnification.
To confirm tissue integrity, some slides were subjected to
hematoxylin/eosin staining and examined under bright-
field illumination.
Immunocytochemistry
Cryosections (5 µm) were incubated for 30 min in 0.3%
hydrogen peroxide in methanol to quench endogenous
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peroxidase activity. After washing 3 times with phosphate-
buffered saline (PBS) for 10 min each, slides were incu-
bated with preblocking serum (normal goat serum, 1.5%;
bovine serum albumin, 2%; Triton-X, 0.1%) for 1 h at
room temperature. The primary antibody of Bax, Bcl-xL,
Bcl-2, Bcl-w, and Mtd (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, U.S.A.) was applied at a concentration of
1 µg/ml in preblocking solution and kept at 4◦C overnight.
After washing 3 times with PBS, tissue sections were in-
cubated for 1 h with 3 µg/ml of biotinylated goat anti-
rabbit antibody (Vector Laboratories, Burlingame, CA,
U.S.A.) in the preblocking solution containing 1% nor-
mal rat serum (Sigma), washed in PBS, and incubated
for 1 h with an avidin-biotin complex reagent contain-
ing horseradish peroxidase (HRP) (Vector Laboratories)
in PBS. After washing 10 min with PBS, slides were
rinsed in 0.5% Triton-X 100/PBS for 30 s. Color develop-
ment was achieved by incubation with diaminobenzidine
(DAB) solution (Vector Laboratories) for 7 min. The tis-
sues were examined by using Zeiss-Axioskop microscope
at ×4, ×10, and ×40 magnification.
To analyze immunoreactivity, the number of immuno-
positive cells in sections was semiquantitatively scored
(35). The scoring was as follows: 0, not present (Fig. 4D);
1, light (Fig. 4C, F, G, H, J); 2, moderate (Fig. 4A, E, I);
3, high (Fig. 4B).
In situ analysis of DNA fragmentation (terminal
deoxynucleotidyl transferase–mediated dUTP
nick-end labeling; TUNEL)
DNA fragmentation was detected in situ with a
TdT- (terminal deoxynucleotidyl transferase)–mediated
fluorescein-dUTP labeling kit (Roche Diagnostics,
Mannheim, Germany). Brain cryosections were fixed in
4% paraformaldehyde in PBS for 20 min at room tem-
perature and then washed in PBS for 30 min. After in-
cubating with a permeabilization solution (0.1% Triton
X-100, 0.1% sodium citrate) for 2 min on ice, 50 µl of
TUNEL reaction mixture was put into each sample and
incubated for 1 h at 37◦C in the dark in a humidified cham-
ber. Slides were then directly analyzed with fluorescence
microscopy. For evaluation by fluorescence microscopy,
we used an excitation wavelength in the range of 450–500
nm and detection in the range of 515–565 nm. As neg-
ative control, we incubated the slides in the absence of
TdT. For positive controls, the samples were first treated
with DNase I (1,000 U/ml in 50 mM Tris-HCl, pH 7.5,
1 mg/ml BSA) for 10 min at 20◦C to induce DNA strand
breaks before labeling procedures and then incubated with
50 µl of TUNEL reaction mixture.
RESULTS
Induction of epilepsy in animals (kindling procedure)
To investigate the participation of the bcl-2 family of
genes during the formation period of kindled epilepsy, first
FIG. 1. Patterns of electrographic activity during kindling. EEG
traces were recorded from the electrically stimulated animals on
day 1 (A); day 10 (B); and day 14 (C). After day 10, we observed
stage 4 kindling seizures (rearing and falling on forelimbs).
we performed the kindling procedure to induce epilepsy.
After day 10, we observed stage 4 kindling seizures (rear-
ing and falling on forelimbs) as defined by Racine (34).
As seen from EEG traces, afterdischarges were evident
after applying electrical stimulus on day 1 (Fig. 1A). We
observed epileptic EEG activity on day 10 (Fig. 1B) and
day 14 (Fig. 1C). We did not detect any epileptic activity
in the sham and control group of animals in their EEG
traces (data not shown).
To elucidate the role of the bcl-2 family of genes and
apoptosis during epileptogenesis, we investigated the ex-
pression pattern of different bcl-2 family of genes (bax,
bcl-xL bcl-2, mtd, bcl-w) at both the mRNA and protein
levels, by monitoring at different stages of the kindling
model of epilepsy in rats by using in situ hybridization,
immunohistochemistry, and in situ analysis of DNA frag-
mentation (TUNEL).
bax mRNA expression
We observed bax mRNA expression in the hippocam-
pal CA1 area as early as 1 day after the electrical stimulus
(Fig. 2A). In the corresponding sham group of animals on
day 1, bax mRNA expression also was present but to a
lesser extent (Fig. 2B). Decreased expression in the sham
group suggests that the increase in the expression of bax
is due to electrical stimulus. Increased mRNA expression
of bax was observed on day 9 (data not shown), but it was
more evident at day 10 (Fig. 2C). Similar to day 10, bax
expression persisted on day 14 (data not shown). Con-
versely, bax expression was not detectable in the sham
group of animals on day 10 (Fig. 2D). By using sense bax
mRNA as a control, we did not detect any specific bind-
ing (Fig. 2E). We also observed morphologic changes in
the limbic lobe tissues starting on day 10 (Fig. 2C). These
changes were not present in sham group animals on day 10
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FIG. 2. The expression of bax mRNA in CA1 region (F) during the
formation of kindling. The expression of bax mRNA was examined
by using antisense (A–D) and sense (E) bax riboprobes on day 1
(A) and day 10 (C) of electrically stimulated animals and compared
to that of sham group on day 1 (B) and day 10 (D). A: bax mRNA
expression was present in CA1 region of electrically stimulated rat
brains on day 1. Inset, bax mRNA-positive and -negative staining
area shown at high power. B: Decreased expression of bax mRNA
in CA1 region of sham groups on day 1. C: bax mRNA expression
increased on day 10 of electrically stimulated rat brains. Inset, bax
mRNA-positive and -negative staining area shown at high power.
D: No detectable bax mRNA expression in CA1 region of sham
groups on day 10. E: Section probed with sense bax riboprobes
revealed no specific binding. F: Cross section of brain at 35th
plate, red rectangle denotes CA 1 region. Arrows, indicate the
CA1 region in the brain tissues. DG, dentate gyrus.
(Fig. 2D), which rules out the local irritation of implanted
electrodes.
bcl-xL mRNA expression
We found similar expression levels of bcl-xL mRNA at
the CA1 region both in the electrically stimulated (Fig.
3A) and the sham group of animals (Fig. 3B) on day 1.
This suggested that a basal level of expression existed,
and this expression was not affected by electrical stimulus.
Interestingly, when we examined the later stages, bcl-xL
expression almost diminished on day 8 (data not shown)
and day 10 of electrically stimulated animals (Fig. 3C).
In contrast, on day 10, a similar level of bcl-xL expression
was present in both sham (Fig. 3D) and control groups
(data not shown) compared with day 1. By using sense
bcl-xL mRNA, we did not detect any specific binding (Fig.
3E). The expression of bcl-xL was absent on day 14 in the
electrically stimulated animals (data not shown).
bcl-2, mtd, and bcl-w gene expression
We did not detect any modulation in the expression of
these genes in our in situ hybridization experiments (data
not shown).
FIG. 3. The expression of bcl-xL mRNA in CA1 region (F) dur-
ing the formation of kindling. The expression of bcl-xL mRNA was
examined by using antisense (A–D) and sense (E) bcl-xL ribo-
probes on day 1 (A) and day 10 (C) of electrically stimulated an-
imals and compared to that of sham group on day 1 (B) and day
10 (D). A: bcl-xL mRNA expression was detected in CA1 region
of electrically stimulated rat brains on day 1. B: Similar levels of
the expression of bcl-xL mRNA in CA1 region of sham groups on
day 1. C: bcl-xL mRNA expression was not detectable on day 10
of electrically stimulated rat brains. Inset, bcl-xL mRNA-negative
staining area shown at high power. D: The expression of bcl-xL
mRNA was present in CA1 region of sham groups on day 10. E:
Section probed with sense bcl-xL riboprobes revealed no specific
binding. F: Cross section of brain at 35th plate, red rectangle de-
notes CA 1 region. Arrows indicate the CA1 region in the brain
tissues. DG, dentate gyrus.
Bax protein expression
We observed increased Bax protein expression on day
10 (Fig. 4B) compared with day 1 (Fig. 4A) with respect to
electrically stimulated animals. Bax expression persisted
on day 14 (data not shown). However, in the sham animals,
a very light expression was noted on day 1 (Fig. 4C), and
no expression was seen on day 10 (Fig. 4D). In electri-
cally stimulated animals, the expression level of Bax on
day 7 (Fig. 4I) was less than to that of day 10 but more
than that of day 1. No differences were seen in the expres-
sion of control animals between days 1 and 10 (data not
shown). No staining was seen in negative controls (data
not shown).
Bcl-xL protein expression
Similar to its mRNA expression, we observed decreased
Bcl-xL protein expression in the stimulated groups of an-
imals on day 10 (Fig. 4F) compared with day 1 (Fig. 4E).
Conversely, in the sham groups of animals, the expres-
sion levels were similar on days 1 (Fig. 4G) and 10 (Fig.
4H). Compared with Bax expression, an opposite pattern
of expression in Bcl-xL was observed on day 7 of group
of electrically stimulated animals. The level of Bcl-xL ex-
pression on day 7 (Fig. 4J) was less than that of day 1 but
more than that of day 10. No expression of Bcl-xL was
observed on day 14 in the electrically stimulated animals
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FIG. 4. The expression of Bax (A–D, I) and Bcl-xL (E–H, J) protein in CA1 region during the formation of kindling. The expression of
Bax on day 1 (A) and day 10 (B) of electrically stimulated animals, compared to that of sham group on day 1 (C) and day 10 (D). Bax
protein expression increased on day 10 in electrically stimulated animals. The expression of Bcl-xL protein on day 1 (E) and day 10 (F) of
electrically stimulated animals compared to that of sham group on day 1 (G) and day 10 (H). The levels of Bcl-xL protein was decreased
in the stimulated group on day 10, whereas in the sham groups, there was no difference between the expression on day 1 and day 10. To
illustrate the effect of electrical stimulation on the expression of these proteins during kindling, the level of Bax and Bcl-xL proteins was
also assessed on day 7 (I and J, respectively). Arrows indicate the CA1 region in the brain tissues. Arrowheads indicate immune reactive
cells. DG, dentate gyrus.
(data not shown). No differences were seen in the expres-
sion of control animals between days 1 and 10 (data not
shown). To assess the specific binding, no expression was
observed when the primer antibody was omitted (data not
shown).
Bcl-2, Mtd, and Bcl-w protein expressions
We did not find any changes in the expression levels
of Bcl-2, Mtd, and Bcl-w protein in our groups (data not
shown).
In situ analysis of DNA fragmentation (TUNEL)
Increased Bax and decreased Bcl-xL expression both
in mRNA and protein levels during kindling suggested
the presence of apoptosis, because the ratio between these
genes has been altered to favor apoptotic death. There-
fore we investigated the onset of apoptosis by examining
the DNA fragmentation. However, we did not detect any
TUNEL-positive cell in any of the day 1 and day 14 groups
(Fig. 5A and B). Conversely, when we treated the tissue
with DNase I to induce DNA strand breaks, as a positive
control, we found many TUNEL-positive cells (Fig. 5C).
FIG. 5. Assessment of the presence of DNA fragmentation by
TUNEL during the formation of kindling. No positive cells was
seen on day 1 (A) and day 10 (B). On the other hand, there were
many TUNEL-positive cells when the sections were treated with
DNase I to induce DNA breaks (C).
DISCUSSION
This study characterized the expression pattern of the
bcl-2 family of genes at both mRNA and protein levels
during epileptogenesis in a highly successful experimen-
tal murine model of kindling. By using this animal model,
previously Zhang et al. (12) observed an increased ratio
of bax/bcl-2 mRNA expression and apoptosis in the hip-
pocampus of adult rats after the formation of seizures.
In this study, we went one step beyond and investigated
the involvement of the bcl-2 family of genes at both the
mRNA and protein levels during the formation process of
epileptic seizures by using in situ hybridization, immuno-
histochemistry, and in situ analysis of DNA fragmentation
(TUNEL) experiments.
Abnormal excitability has been identified in neurons or
synapses in multiple sites in the kindled brain by electro-
physiologic analyses of in vitro brain slices; these sites
include the dentate granule cells, CA3 and CA1 pyrami-
dal cells of the hippocampus, pyramidal neurons of the
pyriform cortex, and neurons in the basolateral nucleus
of the amygdala (36–39). The amygdala, which requires
relatively little stimulation to induce kindling, is a particu-
larly convenient structure because of its large size, simpli-
fying the stereotaxic placement of a stimulating/recording
electrode (39). In our study, we preferred to stimulate par-
ticularly the CA1 region to have a prolonged period of kin-
dling to observe early apoptotic events more easily during
epileptogenesis.
Extensive studies performed over the last 10 years have
revealed considerable information on the molecular ba-
sis of apoptosis. The mitochondria play an essential role
in the apoptotic death of mammalian cells by releasing
various apoptogenic proteins, including cytochrome c,
into the cytoplasm (16,17). The Bcl-2 family of proteins
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regulates these mitochondrial changes during apoptosis.
One of the major function of the Bcl-2 protein family
is to control membrane permeability directly, although
the precise mechanisms by which Bcl-2 family mem-
bers do so are still to be determined. It has been pro-
posed that the ratio of the expression within the members
of this family is critical in the fate of a cell; whether it
should live or undergo programmed cell death (18,19).
Therefore we chose to detect the expression levels of bax,
bcl-2, bcl-xL, bcl-w, and mtd among the bcl-2 family of
genes.
Alterations within some of the Bcl-2 family of proteins
have been shown both in human temporal lobe epilepsy
(20,21) and in different experimental murine models of
epilepsy (12,23–32). Our results provide evidence that al-
though subthreshold electrical stimuli generate an epilep-
tic focus during kindling, they also cause differential bax
and bcl-xL gene expression in CA1 region, resulting in dis-
ruption of the delicate balance within the expression of the
bcl-2 family of genes. During the formation of the kindling
procedure, the expression of bax increases, whereas bcl-
xL expression decreases at the hippocampal CA1 region,
at both mRNA and protein levels. Particularly interest-
ing is that the balance between the expression of Bax and
Bcl-xL is shifted in favor of Bax on day 10 of the kin-
dling procedure. Detection of Bcl-xL but not Bax expres-
sion in the corresponding sham and control group of ani-
mals further supports this contention. This finding implies
that neuronal morphologic or functional changes or both
due to epileptogenesis could be responsible for trigger-
ing apoptotic events. However, new studies are warranted
to show the physical interaction of Bax-Bcl-xL, such as
co-immunoprecipitation.
We also observed that electrically stimulated animals
developed a distinct histologic profile 10 days after the
first electrical stimulus. The intensity of the current that we
used during kindling formation was very low and, as de-
fined by Engel (40), this low intensity of electricity while
inducing kindling does not result in histologic damage.
In addition, electrical impulses in the earlier days (be-
fore day 10) did not cause this histologic appearance. Not
observing this appearance in the sham group of animals
rules out local irritation due to implants. The epileptic dis-
charges that caused stage 4 kindling seizures in these ani-
mals may be responsible for this appearance by changing
the metabolic activity of the epileptic tissue. It is known
that when epileptic discharges continue for a long time,
morphologic changes in the tissue can be induced. More-
over, functional loss due to the epileptic discharge (Todd
paresis) after a focal epileptic seizure is an indicator of
the presence of histopathologic changes in the tissue (40).
Tissue edema, which is considered one such change, may
be associated with the appearance that we observed after
epileptic seizure. Despite the lack of studies regarding to
histopathologic changes after kindling seizures, this view
also could be related to increased hippocampal volume
(41,42).
Internucleosomal DNA fragmentation is considered to
be a biochemical hallmark of apoptosis. Several studies
have used this simple method in a wide variety of CNS
disorders to identify apoptotic cells (43). However, we did
not detect any DNA fragmentation with our TUNEL as-
say within our groups. One explanation for the absence
of DNA fragmentation in our experimental system might
be that we observed an early period of apoptosis. Because
DNA fragmentation is a late event in the apoptotic pro-
cesses, TUNEL negativity does not necessarily exclude
a stage of the initial apoptotic process. Observing the
TUNEL positivity in our positive control group also rules
out the possibility of a methodologic flaw. Alternatively,
other members of the Bcl-2 family of proteins may inter-
act with Bax or Bcl-xL or both to prevent the release of
cytochrome c from mitochondria, which ultimately blocks
the activity caspases, and thus the onset of apoptosis. Nev-
ertheless, the functional importance of cytochrome c in
kindled rats is not known.
In addition, TUNEL negativity may be related to the
intracellular localization of Bax protein. It is known that
Bax is localized in the cytoplasm, and on receiving a death
signal, it is translocated to the mitochondria and starts a
cascade of events resulting in the release of cytochrome c
(44), leading to apoptosis. The translocation of Bax protein
also has been shown to participate in neuronal cell death
(45). It may be possible that Bax is not translocated into the
mitochondria because of its interaction with a molecular
chaperone protein 14-3-3, which negatively regulates the
activity of Bax (46). Furthermore, another member of the
Bcl-2 family of protein, Bad, has been shown to displace
Bax from Bcl-xL, resulting in the translocation of Bax
to the mitochondria (25). Therefore in our experimental
system, Bad may be one of the factors responsible for
the lack of DNA fragmentation. Studies to assess protein–
protein interaction dynamics and dimerization responses
of Bcl-2 family proteins are required to assess the role of
these proteins properly during the kindling process.
In summary, we investigated the expression levels of the
Bcl-2 family of proteins during the formation of kindling
epileptogenesis and found that differential expression of
Bax and Bcl-xL at CA1 region accompanied the formation
of the epileptic focus. Because these modulations occurred
before the onset of apoptosis, it can be concluded that
epileptic changes in neurons have the potential to induce
apoptosis through regulation of Bax and Bcl-xL. Better
understanding of this regulation may result in new genetic
treatments to prevent the formation of epilepsy.
Acknowledgment: This study was supported in part by
Bilkent University Research Grant, Bilkent University Faculty
Development Grant, Ege University, and Tubitak (SBAG-2239).
We also thank Dr. Sakire Pogun and Dr. Gonul Peker for their
invaluable help in the kindling procedure.
Epilepsia, Vol. 46, No. 2, 2005
bcl-2 FAMILY OF GENES DURING EPILEPTOGENESIS 223
REFERENCES
1. Babb TL, Brown WJ, Pretorius J, et al. Temporal lobe volumetric
cell densities in temporal lobe epilepsy. Epilepsia 1984;25:729–
40.
2. Kim JH, Guimaraes PO, Shen MY, et al. Hippocampal neuronal
density in temporal lobe epilepsy with and without gliomas. Acta
Neuropathol 1990;80:41–5.
3. Sagar HJ, Oxbury JM. Hippocampal neuron loss in temporal lobe
epilepsy: correlations with early childhood convulsions. Ann Neurol
1987;22:334–40.
4. Ebert U, Brandt C, Loscher W. Delayed sclerosis, neuro-protection,
and limbic epileptogenesis after status epilepticus in the rat. Epilep-
sia 2002;43:86–95.
5. Fujikawa DG, Shinmei SS, Cai B. Kainic acid-induced seizures pro-
duce necrotic, not apoptotic, neurons with internucleosomal DNA
cleavage: implications for programmed cell death mechanism. Neu-
roscience 2000;98:41–53.
6. Kubova H, Druga R, Lukasiuk K, et al. Status epilepticus causes
necrotic damage in the mediodorsal nucleus of the thalamus in im-
mature rats. J Neurosci 2001;21:3593–9.
7. Puig B, Ferrer I. Caspase-3-associated apoptotic cell death in ex-
citotoxic necrosis of the entorhinal cortex following intraperitoneal
injection of kainic acid in the rat. Neurosci Lett 2002;321:182–6.
8. Ekdahl CT, Mohapel P, Elmer E, et al. Caspase inhibitors increase
short-term survival of progenitor-cell progeny in the adult rat dentate
gyrus following status epilepticus. Eur J Neurosci 2001;14:937–
45.
9. Sankar R, Shin DH, Liu H, et al. Patterns of status epilepticus-
induced neuronal injury during development and long-term conse-
quences. J Neurosci 1998;18:8382–93.
10. Bengzon J, Kokaia Z, Elmar E, et al. Apoptosis and proliferation of
dentate gyrus neurons after single and intermittent limbic seizures.
Proc Natl Acad Sci U S A 1997;94:10432–7.
11. Sloviter RS, Dean E, Sollas AL, et al. Apoptosis and necrosis in-
duced in different hippocampal neuron populations by repetitive
perforant path stimulation in the rat. J Comp Neurol 1996;366:516–
33.
12. Zhang LX, Smith MA, Li XL, et al. Apoptosis of hippocampal
neurons after amygdala kindled seizures. Brain Res Mol Brain Res
1998;55:198–208.
13. Goddard GV, McIntyre DC, Leech CK. A permanent change in
brain function resulting from daily electrical stimulation. Exp Neurol
1969;25:295–330
14. McNamara JO. The neurobiological basis of epilepsy. Trends Neu-
rosci 1992;15:357–9
15. Dam AM. Epilepsy and neuron loss in the hippocampus. Epilepsia
1980;21:617–29.
16. Martinou JC, Green DR. Breaking the mitochondrial barrier. Nat
Rev Mol Cell Biol 2001;2:63–7.
17. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pan-
dora’s box opens. Nat Rev Mol Cell Biol 2001;2:67–71.
18. Festjens N, van Gurp M, van Loo G, et al. Bcl-2 family members
as sentinels of cellular integrity and role of mitochondrial inter-
membrane space proteins in apoptotic cell death. Acta Haematol
2004;111:7–27.
19. Sedlak TW, Oltvai ZN, Yang EM, et al. Multiple Bcl-2 family mem-
bers demonstrate selective dimerizations with Bax. Proc Natl Acad
Sci U S A 1995;92:7834–8.
20. Henshall DC, Clark RS, Adelson PD, et al. Alterations in bcl-2
and caspase gene family protein expression in human temporal lobe
epilepsy. Neurology 2000;55:250–7.
21. Uysal H, Cevik IU, Soylemezoglu F, et al. Is the cell death in mesial
temporal sclerosis apoptotic? Epilepsia 2003;44:778–84.
22. Nagy Z, Esiri MM. Neuronal cyclin expression in the hippocampus
in temporal lobe epilepsy. Exp Neurol 1998;150:240–7.
23. Shinoda S, Schindler CK, Quan-Lan J, et al. Interaction of 14-3-
3 with Bid during seizure-induced neuronal death. J Neurochem
2003;86:460–9.
24. Fannjiang Y, Kim CH, Huganir RL, et al. BAK alters neuronal
excitability and can switch from anti- to pro-death function during
postnatal development. Dev Cell 2003;4:575–85.
25. Henshall DC, Araki T, Schindler CK, et al. Activation of Bcl-
2-associated death protein and counter-response of Akt within
cell populations during seizure-induced neuronal death. J Neurosci
2002;22:8458–65.
26. Bengzon J, Mohapel P, Ekdahl CT, et al. Neuronal apoptosis after
brief and prolonged seizures. Prog Brain Res 2002;135:111–9.
27. Kondratyev A, Sahibzada N, Gale K. Electroconvulsive shock ex-
posure prevents neuronal apoptosis after kainic acid-evoked status
epilepticus. Brain Res Mol Brain Res 2001;91:1–13.
28. Henshall DC, Skradski SL, Lan J, et al. Increased Bcl-W expression
following focally evoked limbic seizures in the rat. Neurosci Lett
2001;305:153–6.
29. Ananth C, Thameem Dheen S, Gopalakrishnakone P, et al. Domoic
acid-induced neuronal damage in the rat hippocampus: changes in
apoptosis related genes (bcl-2, bax, caspase-3) and microglial re-
sponse. J Neurosci Res 2001;66:177–90.
30. Lopez E, Pozas E, Rivera R, et al. Bcl-2, Bax and Bcl-x expression
following kainic acid administration at convulsant doses in the rat.
Neuroscience 1999;9:1461–70.
31. Tan Z, Sankar R, Tu W, et al. Immunohistochemical study of p53-
associated proteins in rat brain following lithium-pilocarpine status
epilepticus. Brain Res 2002;929:129–38.
32. Tuunanen J, Lukasiuk K, Halonen T, et al. Status epilepticus-
induced neuronal damage in the rat amygdaloid complex: distribu-
tion, time-course and mechanisms. Neuroscience 1999;94:473–95.
33. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San
Diego: Academic Press, 1986.
34. Racine RJ. Modification of seizure activity by electrical stimu-
lation, II: motor seizure. Electroencephalogr Clin Neurophysiol
1972;32:281–94.
35. Narkilahti S, Pirttila TJ, Lukasiuk K, et al. Expression and activation
of caspases 3 following status epilepticus in the rat. Eur J Neurosci
2003;18:1486–96.
36. Bragdon AC, Taylor DM, McNamara JO, et al. Abnormal hyperex-
citability of hippocampal slices from kindled rats is transient. Brain
Res 1988;453:267–4.
37. Gean PW, Shinnick Gallagher P, et al. Spontaneous epileptiform
activity and alteration of GABA- and of NMDA-mediated neurons
kindled in vivo. Brain Res 1989;494:177–81.
38. King GL, Dingledine R, Giacchino JL, et al. Abnormal neuronal
excitability in hippocampal slices from kindled rats. J Neurophysiol
1985;54:1295–304.
39. McNamara JO, Wada JA. Kindling model. In: Engel J Jr, Pedley TA,
eds. Epilepsy; a comprehensive textbook. Philadelphia: Lippincott-
Raven, 1997:419–25.
40. Engel J Jr. Basic mechanisms of epilepsy. In: Engel J Jr, ed. Seizures
and Epilepsy. Philadelphia: FA Davis Company, 1989:102.
41. Adams RA, Maurice V, Allan HR. Epilepsy and other seizure dis-
orders. In: Victor M, Ropper AH, eds. Principles of Neurology.
New York: McGraw-Hill, 1997:326.
42. Sutula TP. Experimental models of temporal lobe epilepsy: new
insights from the study of kindling and synaptic reorganization.
Epilepsia 1990;31(suppl 3):S45–54.
43. Liou AKF, Clark RS, Henshall DC, et al. To die or not to die for
neurons in ischemia, traumatic brain injury and epilepsy: a review
on the stress-activated signaling pathways and apoptotic pathways.
Prog Neurobiol 2003;69:103–42.
44. Wolter KG, Hsu Y, Smith CL, et al. Movement of Bax from the cy-
tosol to mitochondria during apoptosis. J Cell Biol 1997;139:1281–
92.
45. Kirkland RA, Windelborn JA, Kasprzak JM, et al. A Bax-induced
pro-oxidant state is critical for cytochrome c release during pro-
grammed neuronal death. J Neurosci 2002;22:6480–90.
46. Nomura M, Shimizu S, Sugiyama T, et al. 14-3-3 Interacts di-
rectly with and negatively regulates pro-apoptotic Bax. J Biol Chem
2003;278:2058–65.
Epilepsia, Vol. 46, No. 2, 2005
